Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma

被引:3
|
作者
Li, Xiumei [1 ]
Chen, Jianwei [2 ]
Zhang, Chengxiu [3 ]
Han, Zewen [1 ]
Zheng, Xiuying [1 ]
Cao, Dairong [1 ,4 ,5 ,6 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Fuzhou 350005, Fujian, Peoples R China
[2] Fujian Prov Canc Hosp, Dept Pathol, Fuzhou 350014, Fujian, Peoples R China
[3] East China Normal Univ, Sch Phys & Elect Sci, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Natl Reg Med Ctr, Dept Radiol, Binhai Campus, Fuzhou 350212, Fujian, Peoples R China
[5] Fujian Med Univ, Affiliated Hosp 1, Fujian Key Lab Precis Med Canc, Fuzhou 350005, Fujian, Peoples R China
[6] Fujian Med Univ, Affiliated Hosp 1, Key Lab Radiat Biol, Fujian Higher Educ Inst, Fuzhou 200062, Peoples R China
关键词
Lung adenocarcinoma; Radiomics; Computed tomography; T790M; CANCER;
D O I
10.1186/s12890-023-02609-y
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundThe purpose of this study was to develop a radiomic nomogram to predict T790M mutation of lung adenocarcinoma base on non-enhanced CT lung images.MethodsThis retrospective study reviewed demographic data and lung CT images of 215 lung adenocarcinoma patients with T790M gene test results. 215 patients (including 52 positive) were divided into a training set (n = 150, 36 positive) and an independent test set (n = 65, 16 positive). Multivariate logistic regression was used to select demographic data and CT semantic features to build clinical model. We extracted quantitative features from the volume of interest (VOI) of the lesion, and developed the radiomic model with different feature selection algorithms and classifiers. The models were trained by a 5-fold cross validation strategy on the training set and assessed on the test set. ROC was used to estimate the performance of the clinical model, radiomic model, and merged nomogram.ResultsThree demographic features (gender, smoking, emphysema) and ten radiomic features (Kruskal-Wallis as selection algorithm, LASSO Logistic Regression as classifier) were determined to build the models. The AUC of the clinical model, radiomic model, and nomogram in the test set were 0.742(95%CI, 0.619-0.843), 0.810(95%CI, 0.696-0.907), 0.841(95%CI, 0.743-0.938), respectively. The predictive efficacy of the nomogram was better than the clinical model (p = 0.042). The nomogram predicted T790M mutation with cutoff value was 0.69 and the score was above 130.ConclusionThe nomogram developed in this study is a non-invasive, convenient, and economical method for predicting T790M mutation of lung adenocarcinoma, which has a good prospect for clinical application.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma
    Xiumei Li
    Jianwei Chen
    Chengxiu Zhang
    Zewen Han
    Xiuying zheng
    Dairong Cao
    BMC Pulmonary Medicine, 23
  • [2] Genomic Evolution in a Patient With Lung Adenocarcinoma With a Germline EGFR T790M Mutation
    Maekinen, Netta
    Zhou, Meng
    Bemus, Meredith
    Nevin, Julius
    Nag, Anwesha
    Chen, Ruthia
    Colson, Yolonda L.
    Thorner, Aaron R.
    Oxnard, Geoffrey R.
    Meyerson, Matthew
    Sholl, Lynette M.
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (04):
  • [3] Clinical Impact of Pretreatment EGFR T790M Mutation in Lung Adenocarcinoma Patients
    Macerola, Elisabetta
    Bruno, Rossella
    Prediletto, Irene
    Sensi, Elisa
    Chella, Antonio
    Landi, Lorenza
    Ali, Greta
    Fontanini, Gabriella
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1207 - S1207
  • [4] A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma
    Lu, Xiaoqian
    Li, Mingyang
    Zhang, Huimao
    Hua, Shucheng
    Meng, Fanyang
    Yang, Hualin
    Li, Xueyan
    Cao, Dianbo
    PHYSICS IN MEDICINE AND BIOLOGY, 2020, 65 (05)
  • [5] Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma
    Fan, Ying
    Dong, Yue
    Wang, Huan
    Wang, Hongbo
    Sun, Xinyan
    Wang, Xiaoyu
    Zhao, Peng
    Luo, Yahong
    Jiang, Xiran
    EUROPEAN RADIOLOGY, 2022, 32 (10) : 6739 - 6751
  • [6] T790M: A Favorable Mutation?
    Lan, Shen
    Jian, Hong
    Yu, Yongfeng
    Lu, Shun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1205 - S1205
  • [7] Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR
    Sakai, Hitomi
    Hayashi, Hidetoshi
    Iwasa, Tsutomu
    Hasegawa, Yoshikazu
    Takeda, Masayuki
    Nakagawa, Kazuhiko
    ESMO OPEN, 2017, 2
  • [8] Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
    Yang, Xiaohuang
    Fang, Chao
    Li, Congrui
    Gong, Min
    Yi, Xiaochun
    Lin, Huashan
    Li, Kunyan
    Yu, Xiaoping
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation
    Lee, Sang Hoon
    Kim, Eun Young
    Kim, Arum
    Chang, Yoon Soo
    CANCER BIOLOGY & THERAPY, 2020, 21 (08) : 741 - 748
  • [10] Usefulness of Nanofluidic Digital PCR Arrays to Quantify T790M Mutation in EGFR-mutant Lung Adenocarcinoma
    Isobe, Kazutoshi
    Hata, Yoshinobu
    Tochigi, Naobumi
    Kaburaki, Kyohei
    Kobayashi, Hiroshi
    Makino, Takashi
    Otsuka, Hajime
    Ishida, Fumiaki
    Hirota, Nao
    Sano, Go
    Sugino, Keishi
    Sakamoto, Susumu
    Takai, Yujiro
    Shibuya, Kazutoshi
    Iyoda, Akira
    Homma, Sakae
    CANCER GENOMICS & PROTEOMICS, 2015, 12 (01) : 31 - 37